Loading...
Therapeutic Challenges for Cisplatin-Resistant Ovarian Germ Cell Tumors
The majority of patients with advanced ovarian germ cell cancer are treated by cisplatin-based chemotherapy. Despite adequate first-line treatment, nearly one third of patients relapse and almost half develop cisplatin-resistant disease, which is often fatal. The treatment of cisplatin-resistant dis...
Na minha lista:
| Udgivet i: | Cancers (Basel) |
|---|---|
| Main Authors: | , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
MDPI
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6826947/ https://ncbi.nlm.nih.gov/pubmed/31627378 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers11101584 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|